Indo US Bio-Tech Ltd. (IN:INDOUS)
:INDOUS
Want to see IN:INDOUS full AI Analyst Report?
Total Valuation
Indo US Bio-Tech Ltd. has a market cap or net worth of ₹1.79B. The enterprise value is ₹2.27B.
Market Cap₹1.79B
Enterprise Value₹2.27B
Share Statistics
Indo US Bio-Tech Ltd. has 20,052,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,052,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Indo US Bio-Tech Ltd.’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 11.71%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)11.71%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee1.25M
Profits Per Employee157.65K
Employee Count883
Asset Turnover0.83
Inventory Turnover0.80
Valuation Ratios
The current PE Ratio of Indo US Bio-Tech Ltd. is 13.7. Indo US Bio-Tech Ltd.’s PEG ratio is 0.00232.
PE Ratio13.7
PS Ratio1.87
PB Ratio2.24
Price to Fair Value2.24
Price to FCF-13.80
Price to Operating Cash Flow-24.06
PEG Ratio0.00232
Income Statement
In the last 12 months, Indo US Bio-Tech Ltd. had revenue of 1.10B and earned 131.23M in profits. Earnings per share was 6.54.
Revenue1.10B
Gross Profit301.69M
Operating Income161.09M
Pretax Income139.20M
Net Income131.23M
EBITDA170.66M
Earnings Per Share (EPS)6.54
Cash Flow
In the last 12 months, operating cash flow was -74.56M and capital expenditures -8.79M, giving a free cash flow of -83.36M billion.
Operating Cash Flow-74.56M
Free Cash Flow-83.36M
Free Cash Flow per Share-4.16
Dividends & Yields
Indo US Bio-Tech Ltd. pays an annual dividend of ₹0.25, resulting in a dividend yield of ―
Dividend Per Share₹0.25
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.94
52-Week Price Change-40.95%
50-Day Moving Average102.93
200-Day Moving Average122.73
Relative Strength Index (RSI)28.16
Average Volume (3m)983.00
Important Dates
Indo US Bio-Tech Ltd. upcoming earnings date is Aug 7, 2026, TBA (Not Confirmed).
Last Earnings DateMay 30, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Indo US Bio-Tech Ltd. as a current ratio of 3.05, with Debt / Equity ratio of 40.02%
Current Ratio3.05
Quick Ratio0.52
Debt to Market Cap0.18
Net Debt to EBITDA1.81
Interest Coverage Ratio7.18
Taxes
In the past 12 months, Indo US Bio-Tech Ltd. has paid 7.97M in taxes.
Income Tax7.97M
Effective Tax Rate0.06
Enterprise Valuation
Indo US Bio-Tech Ltd. EV to EBITDA ratio is 13.93, with an EV/FCF ratio of -15.86.
EV to Sales2.15
EV to EBITDA13.93
EV to Free Cash Flow-15.86
EV to Operating Cash Flow-18.90
Balance Sheet
Indo US Bio-Tech Ltd. has ₹5.88M in cash and marketable securities with ₹276.43M in debt, giving a net cash position of -₹270.56M billion.
Cash & Marketable Securities₹5.88M
Total Debt₹276.43M
Net Cash-₹270.56M
Net Cash Per Share-₹13.49
Tangible Book Value Per Share₹46.12
Margins
Gross margin is 27.32%, with operating margin of 14.59%, and net profit margin of 11.88%.
Gross Margin27.32%
Operating Margin14.59%
Pretax Margin12.60%
Net Profit Margin11.88%
EBITDA Margin15.45%
EBIT Margin14.64%
Analyst Forecast
The average price target for Indo US Bio-Tech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.36%
EPS Growth Forecast-19.37%